BMJ 2003;326:1115 (24 May), doi:10.1136/bmj.326.7399.1115
Paper
Stepping down inhaled corticosteroids in asthma: randomised controlled trial
Gillian Hawkins, clinical research fellow1,
Alex D McMahon, senior statistician2,
Sara Twaddle, head of research and development3,
Stuart F Wood, senior lecturer1,
Ian Ford, professor2,
Neil C Thomson, professor4
1 Department of General Practice, University of Glasgow, Glasgow G12 0RR,
2 Robertson Centre for Biostatistics, University of Glasgow, Glasgow G12
8QQ,
3 Department of Research and Development, Stobhill Hospital, Glasgow G21
3UT,
4 Department of Respiratory Medicine, University of Glasgow, Western Infirmary,
Glasgow G11 6NT
Correspondence to: N C Thomson
n.c.thomson{at}clinmed.gla.ac.uk
Objectives To determine whether the dose of inhaled corticosteroids
can be stepped down in patients with chronic stable asthma while maintaining
control. Design One year, randomised controlled, double blind, parallel
group trial.
Setting General practices throughout western and central
Scotland.
Participants 259 adult patients with asthma receiving regular
treatment with inhaled corticosteroids at high dose (mean dose 1430 µg
beclomethasone dipropionate).
Interventions Participants were allocated to receive either no
alteration to their dose of inhaled corticosteroid (control) or a 50%
reduction in their dose if they met criteria for stable asthma (stepdown).
Main outcome measures Comparison of asthma exacerbation rates,
asthma related visits to general practice and hospital, health status
measures, and corticosteroid dosage between the two groups.
Results The proportions of subjects with asthma exacerbations were
not significantly different (stepdown 31%, control 26%, P=0.354). Similarly,
the numbers of visits to general practice or hospital and the disease specific
and generic measures of health status over the one year period were not
significantly different. On average the stepdown group received 348 µg (95%
confidence interval 202 µgto494 µg) of beclomethasone dipropionate less
per day than the controls (a difference of 25%), with no difference in the
annual dose of oral corticosteroids between the two treatment regimens.
Conclusions By adopting a stepdown approach to the use of inhaled
steroids at high doses in asthma a reduction in the dose can be achieved
without compromising asthma control.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Relevant Article
-
Patients with stable asthma may be able to take less inhaled corticosteroid
BMJ 2003 326: 0.
[Full Text]
This article has been cited by other articles:
-
Reddel, H. K., Taylor, D. R., Bateman, E. D., Boulet, L.-P., Boushey, H. A., Busse, W. W., Casale, T. B., Chanez, P., Enright, P. L., Gibson, P. G., de Jongste, J. C., Kerstjens, H. A. M., Lazarus, S. C., Levy, M. L., O'Byrne, P. M., Partridge, M. R., Pavord, I. D., Sears, M. R., Sterk, P. J., Stoloff, S. W., Sullivan, S. D., Szefler, S. J., Thomas, M. D., Wenzel, S. E., on behalf of the American Thoracic Society/Europea,
(2009). An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations: Standardizing Endpoints for Clinical Asthma Trials and Clinical Practice. Am. J. Respir. Crit. Care Med.
180: 59-99
[Abstract]
[Full text]
-
Papi, A., Caramori, G., Adcock, I. M., Barnes, P. J.
(2009). Rescue Treatment in Asthma: More Than As-Needed Bronchodilation. Chest
135: 1628-1633
[Abstract]
[Full text]
-
Turner, S, Thomas, M, von Ziegenweidt, J, Price, D
(2009). Prescribing trends in asthma: a longitudinal observational study. Arch. Dis. Child.
94: 16-22
[Abstract]
[Full text]
-
Lucas, A., Smeenk, F., Smeele, I., van Schayck, C.
(2008). Overtreatment with inhaled corticosteroids and diagnostic problems in primary care patients, an exploratory study. Fam Pract
25: 86-91
[Abstract]
[Full text]
-
Bateman, E. D., Hurd, S. S., Barnes, P. J., Bousquet, J., Drazen, J. M., FitzGerald, M., Gibson, P., Ohta, K., O'Byrne, P., Pedersen, S. E., Pizzichini, E., Sullivan, S. D., Wenzel, S. E., Zar, H. J.
(2008). Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J
31: 143-178
[Abstract]
[Full text]
-
Black, P. N., Chen, R., Zitt, M. J., Rachelefsky, G. S., Peters, S. P., Castro, M., Holbrook, J. T.
(2007). Reducing Asthma Treatment. NEJM
357: 504-506
[Full text]
-
Diette, G. B., Patino, C. M., Merriman, B., Paulin, L., Riekert, K., Okelo, S., Thompson, K., Krishnan, J. A., Quartey, R., Perez-Williams, D., Rand, C.
(2007). Patient Factors That Physicians Use to Assign Asthma Treatment. Arch Intern Med
167: 1360-1366
[Abstract]
[Full text]
-
FitzGerald, J M, Gibson, P G
(2006). Asthma exacerbations {middle dot} 4: Prevention.. Thorax
61: 992-999
[Abstract]
[Full text]
-
Paton, J, Jardine, E, McNeill, E, Beaton, S, Galloway, P, Young, D, Donaldson, M
(2006). Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone. Arch. Dis. Child.
91: 808-813
[Abstract]
[Full text]
-
Bruton, A, Thomas, M
(2006). Breathing therapies and bronchodilator use in asthma.. Thorax
61: 643-645
[Full text]
-
Slader, C A, Reddel, H K, Spencer, L M, Belousova, E G, Armour, C L, Bosnic-Anticevich, S Z, Thien, F C K, Jenkins, C R
(2006). Double blind randomised controlled trial of two different breathing techniques in the management of asthma. Thorax
61: 651-656
[Abstract]
[Full text]
-
Smith, A. D., Cowan, J. O., Brassett, K. P., Herbison, G. P., Taylor, D. R.
(2005). Use of Exhaled Nitric Oxide Measurements to Guide Treatment in Chronic Asthma. NEJM
352: 2163-2173
[Abstract]
[Full text]
-
Deykin, A.
(2005). Targeting Biologic Markers in Asthma -- Is Exhaled Nitric Oxide the Bull's-Eye?. NEJM
352: 2233-2235
[Full text]
-
Reddel, H.K.
(2004). Goals of asthma treatment: how high should we go?. Eur Respir J
24: 715-717
[Full text]
-
Barnes, N. C.
(2004). Can Guideline-defined Asthma Control Be Achieved?: The Gaining Optimal Asthma Control Study. Am. J. Respir. Crit. Care Med.
170: 830-831
[Full text]
-
Partridge, M R
(2004). Written asthma action plans. Thorax
59: 87-88
[Full text]
-
Peters, J. I
(2004). Inhaled corticosteroids were safely stepped down in chronic, stable asthma. Evid. Based Med.
9: 16-16
[Full text]
-
(2004). Other articles noted: 25 Jul 03 to 7 Nov 03. Evid. Based Nurs.
7: e1-1
[Full text]
-
(2003). Selections from Journal Watch Pediatrics and Adolescent Medicine. Arch. Dis. Child.
88: 943-944
[Full text]
-
(2003). Corticosteroids in Asthma: Is Less More?. JWatch Pediatrics
2003: 10-10
[Full text]
-
(2003). Reducing the Dose of Inhaled Steroids in Asthma. JWatch General
2003: 3-3
[Full text]
Rapid Responses:
Read all Rapid Responses
- Alternatives to Inhalers
- Sharon J Williams
bmj.com, 23 May 2003
[Full text]
- Asthma diagnosis
- Olle Löwhagen, et al.
bmj.com, 29 May 2003
[Full text]
- Another alternative
- Frank J Leavitt
bmj.com, 29 May 2003
[Full text]
- The impact of illustrations must be considered
- Jane C Davies
bmj.com, 4 Jun 2003
[Full text]
- Further to my response
- Frank J Leavitt
bmj.com, 5 Jun 2003
[Full text]
- Evidence of equivalence rather than difference
- Nick Freemantle
bmj.com, 18 Jun 2003
[Full text]